ForecastedResearch announcementOpportunity FOR-FD-23-015

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

Food and Drug Administration · Department of Health and Human Services

At a glance

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) is a forecasted federal grant opportunity from the Food and Drug Administration (Department of Health and Human Services). The agency's forecast estimates an application due date of April 12, 2023; forecast dates can change. Total estimated funding is $1M across about 30 awards. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 9 more. Cost sharing is not required. It is funded under Assistance Listing 93.103 (Food and Drug Administration Research).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Jul 27, 2022Forecast posted
Oct 13, 2022 (est.)Full notice expected
Apr 12, 2023 (est.)Application deadline

Posted: Jul 27, 2022
Est. close date: Apr 12, 2023
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $1,000,000
Implied average award: $33,333 calculated
Expected awards: 30
Cost sharing: Not required
Funding instrument: Grant
Opportunity category: Discretionary
Fiscal year: FY2023

Typical awards for this program (SAM.gov listing for ALN 93.103, not this notice): Varies by grant mechanism and program specific requirements.

Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.

Who can apply

State governments
County governments
City or township governments
Special district governments
Independent school districts
Public colleges & universities
Federally recognized tribal governments
Public & Indian housing authorities
Native American tribal organizations
501(c)(3) nonprofits
Nonprofits without 501(c)(3) status
Private colleges & universities
For-profit organizations (not small businesses)
Small businesses

Additional information on eligibility (from the notice)

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date.

How to apply

0 of 8 done · progress saved in this browser

Read the full announcement (NOFO)Eligibility, evaluation criteria, page limits and required attachments are in the full notice on Grants.gov. Open ↗
Confirm eligibility and fitCheck your organization type above; no cost sharing is required.
Register (or renew) in SAM.gov and get a UEIFree. New registrations can take several weeks; registrations must be renewed every year. Open ↗
Set up Grants.gov accessCreate a Grants.gov account and make sure someone has the Authorized Organization Representative (AOR) role. Open ↗
Watch for the full noticeThe agency estimates posting it around October 13, 2022. Save this grant to track changes.
Prepare narrative, budget and attachmentsFollow the notice's format exactly — page limits and required forms are common reasons applications are rejected.
Ask the agency contact any questions earlyJanelle Fundersburg Grants Management Specialist · Janelle.Fundersburg@fda.hhs.gov Open ↗
Submit before April 12, 2023Submit a few days early and keep your Grants.gov confirmation and validation emails.

Assistance Listing

What is an ALN?

93.103Food and Drug Administration ResearchProgram →

Reported obligations under ALN 93.103

Historical data · not a prediction

FY18

$173M

FY19

$199M

FY20

$212M

FY21

$219M

FY22

$256M est.

FY23

$247M est.

Source: SAM.gov Assistance Listing 93.103. Program-wide totals, not awards from this specific opportunity.

Who was funded under ALN 93.103

Historical data · not a prediction

Since October 1, 2023, 991 grant awards had funding actions under Food and Drug Administration Research, with 430 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.

THE CRITICAL PATH INSTITUTE$56.2M
NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION$39.7M
ASSOCIATION OF FOOD & DRUG OFFICIALS$29.5M
DUKE UNIVERSITY$19.1M
THE MEDICAL DEVICE INNOVATION CONSORTIUM$15.6M

Recipients, states, recent awards and sub-awards →Source: USAspending.gov.

Agency contact (as published)

Janelle Fundersburg Grants Management Specialist
Janelle.Fundersburg@fda.hhs.gov
301-796-2533

Quick answers

Is “FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)” open for applications yet?

Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around October 13, 2022. Forecast details and dates can change.

Who is eligible to apply for “FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)”?

The official notice names these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 2 more. Additional restrictions may apply; review the full notice.

How much funding is available through “FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)”?

Per the notice, total estimated program funding is $1,000,000 and the agency expects to make about 30 awards.

How do I apply for “FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity FOR-FD-23-015), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

ForecastedALN 93.103